07:00 , Aug 27, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: G protein α inhibiting activity polypeptide 2 (GNAI2)

Hematology INDICATION: Thrombocytopenia Mouse studies suggest inhibiting GNAI2 or other neutrophil extravasation factors could help prevent hemorrhage in thrombocytopenia patients. In a mouse model of thrombocytopenia, antibody-mediated granulocyte depletion prior to immune-mediated blood vessel injury...
08:00 , Jan 5, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Musculoskeletal disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Muscular atrophy G protein alpha inhibiting activity polypeptide 2 (GNAI2) Mouse and tissue culture studies suggest increasing GNAI2 signaling could help promote muscle repair...